DOI: https://doi.org/10.36347/sasjs.2024.v10i08.002

Pages: 915-918

Hepatic hemangioma is a benign tumor that remains latent in most cases and only exceptionally leads to complications. Therefore, therapeutic abstention should be the rule in most cases. Surgical intervention, as a first-line treatment, should be reserved for only symptomatic and complicated forms. Hemangiomas can be safely removed by hepatic resection or enucleation. Enucleation should be the technique of choice when the tumor location and technical factors are favorable. This is a retrospective study including all patients with radiologically or, if necessary, histologically confirmed hepatic hemangiomas, followed up at the Moulay Ismail Military Hospital over a 15-year period. 15 patients were included. The aim of our study is to evaluate the outcomes of different treatments for hepatic hemangiomas, while specifying the epidemiological and anatomoclinical aspects of these tumors, and to deduce the most reasonable therapeutic approach.